Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
FDA product review for daclizumab
Radiation-induced brain injury: low-hanging fruit for neuroregeneration.
Sox10 Expression in Goldfish Retina and Optic Nerve Head in Controls and after the Application of Two Different Lesion Paradigms.
Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy.
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
Tizanidine: Can Buy Uk
Evidence for Mitoxantrone-induced Block of Inwardly Rectifying K Channels Expressed in the Osteoclast Precursor RAW 264.7 Cells Differentiated with Lipopolysaccharide.
Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia.
Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate.
Clinical Epigenetics International Meeting
Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study.
Ampyra (Fampyra)
Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids.
Dimethyl fumarate regulates histone deacetylase expression in astrocytes.
Geography in multiple sclerosis.
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Safety and tolerability of daclizumab HYP treatment in relapsing-remitting multiple sclerosis: results of the DECIDE study
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
American Neurological Association Annual 2012 Annual Meeting
Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.

Pages